Huang YJ, Boushey HA. The microbiome in asthma. J Allergy Clin Immunol. 2015;135(1):25–30.
Article
PubMed
PubMed Central
Google Scholar
Hahn DL. Infectious asthma: a reemerging clinical entity? J Fam Pract. 1995;41(2):153–7.
CAS
PubMed
Google Scholar
Rantala A, Jaakkola JJK, Jaakkola MS. Respiratory infections precede adult-onset asthma. PLoS ONE. 2011;6(12):e27912.
Article
CAS
PubMed
PubMed Central
Google Scholar
Webley WC, Hahn DL. Infection-mediated asthma: Etiology, mechanisms and treatment options, with focus on Chlamydia pneumoniae and macrolides. Respir Res. 2017;18(1):98.
Article
PubMed
PubMed Central
CAS
Google Scholar
Yeh JJ, Wang YC, Hsu WH, Kao CH. Incident asthma and Mycoplasma pneumoniae: a nationwide cohort study. J Allergy Clin Immunol. 2016;137(4):1017–23.
Article
PubMed
Google Scholar
Hahn DL, Anttila T, Saikku P. Association of Chlamydia pneumoniae IgA antibodies with recently symptomatic asthma. Epidemiol Infect. 1996;117(3):513–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Blasi F, Allegra L, Tarsia P, Hahn DL. Chlamydia pneumoniae and asthma. Thorax. 1998;53(12):1095.
Article
CAS
PubMed
Google Scholar
Hahn DL, Dodge RW, Golubjatnikov R. Association of Chlamydia pneumoniae (Strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA J Am Med Assoc. 1991;266(2):225–30.
Article
CAS
Google Scholar
Patel KK, Webley WC. Evidence of infectious asthma phenotype: Chlamydia-induced allergy and pathogen-specific IgE in a neonatal mouse model. PLoS ONE. 2013;8(12):e83453.
Article
PubMed
PubMed Central
CAS
Google Scholar
Hahn DL, Plane MB, Mahdi OS, Byrne GI. Secondary outcomes of a pilot randomized trial of azithromycin treatment for asthma. PLoS Clin Trials. 2006;1(2):e11.
Article
PubMed
PubMed Central
CAS
Google Scholar
Hahn DL, Peeling RW. Airflow limitation, asthma, and Chlamydia pneumoniae-specific heat shock protein 60. Ann Allergy, Asthma Immunol. 2008;101(6):614–8.
Article
Google Scholar
Smith-Norowitz TA, Loeffler J, Huang Y, Klein E, Norowitz YM, Hammerschlag MR, et al. Chlamydia pneumoniae immunoglobulin E antibody levels in patients with asthma compared with non-asthma. Heliyon. 2020;6(2):e03512.
Article
PubMed
PubMed Central
Google Scholar
Redecke V, Dalhoff K, Bohnet S, Braun J, Maass M. Interaction of Chlamydia pneumoniae and human alveolar macrophages: infection and inflammatory response. Am J Respir Cell Mol Biol. 1998;19(5):721–7.
Article
CAS
PubMed
Google Scholar
Grayston JT, Campbell LA, Kuo CC, Mordhorst CH, Saikku P, Thorn DH, et al. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis. 1990;161(4):618–25.
Article
CAS
PubMed
Google Scholar
Johnston SL, Martin RJ. Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis? Am J Respir Crit Care Med. 2005;172(9):1078–89.
Article
PubMed
Google Scholar
Yang J, Hooper WC, Phillips DJ, Talkington DF. Regulation of proinflammatory cytokines in human lung epithelial cells infected with Mycoplasma pneumoniae. Infect Immun. 2002;70(7):3649–55.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chu HW, Honour JM, Rawlinson CA, Harbeck RJ, Martin RJ. Effects of respiratory Mycoplasma pneumoniae infection on allergen-induced bronchial hyperresponsiveness and lung inflammation in mice. Infect Immun. 2003;71(3):1520–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jeong YC, Yeo MS, Kim JH, Lee HB, Oh JW. Mycoplasma pneumoniae infection affects the serum levels of vascular endothelial growth factor and interleukin-5 in atopic children. Allergy Asthma Immunol Res. 2012;4(2):92–7.
Article
CAS
PubMed
Google Scholar
Gil JC, Cedillo RL, Mayagoitia BG, Paz MD. Isolation of Mycoplasma pneumoniae from asthmatic patients. Ann Allergy. 1993;70(1):23–5.
CAS
PubMed
Google Scholar
Juniper EF, Sonia Buist A, Cox FM, Ferrie PJ, King DR. Validation of a standardized version of the asthma quality of life questionnaire. Chest. 1999;115(5):1265–70.
Article
CAS
PubMed
Google Scholar
Juniper EF, O’Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control 2. Eur Respir J. 1999;14(0903–1936):902–7.
Article
CAS
PubMed
Google Scholar
Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113(1):59–65.
Article
PubMed
Google Scholar
Gencay M, Rüdiger JJ, Tamm M, Solér M, Perruchoud AP, Roth M. Increased frequency of Chlamydia pneumoniae antibodies in patients with asthma. Am J Respir Crit Care Med. 2001;163(5):1097–100.
Article
CAS
PubMed
Google Scholar
Cook PJ, Davies P, Tunnicliffe W, Ayres JG, Honeybourne D, Wise R. Chlamydia pneumoniae and asthma. Thorax. 1998;53(4):254–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Pasternack R, Huhtala H, Karjalainen J. Chlamydophila (Chlamydia) pneumoniae serology and asthma in adults: a longitudinal analysis. J Allergy Clin Immunol. 2005;116(5):1123–8.
Article
PubMed
Google Scholar
Sasaki A, Ouchi K, Makata H, Hashimoto K, Matsubara T, Furukawa S. The effect of inhaled corticosteroids on Chlamydophila pneumoniae and Mycoplasma pneumoniae infection in children with bronchial asthma. J Infect Chemother. 2009;15(2):99–103.
Article
CAS
PubMed
Google Scholar
Tuuminen T, Varjo S, Ingman H, Weber T, Oksi J, Viljanen M. Prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae immunoglobulin G and A antibodies in a healthy finnish population as analyzed by quantitative enzyme immunoassays. Clin Diagn Lab Immunol. 2000;7(5):734–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wark PAB, Johnston SL, Simpson JL, Hensley MJ, Gibson PG. Chlamydia pneumoniae immunoglobulin A reactivation and airway inflammation in acute asthma. Eur Respir J. 2002;20(4):834–40.
Article
CAS
PubMed
Google Scholar
Von Hertzen LC. Chlamydia pneumoniae and its role in chronic obstructive pulmonary disease. Ann Med. 1998;30(1):27–37.
Article
Google Scholar
Black PN, Scicchitano R, Jenkins CR, Blasi F, Allegra L, Wlodarczyk J, et al. Serological evidence of infection with Chlamydia pneumoniae is related to the severity of asthma. Eur Respir J. 2000;15(2):254–9.
Article
CAS
PubMed
Google Scholar
Laitinen K, Laurila AL, Leinonen M, Saikku P. Reactivation of Chlamydia pneumoniae infection in mice by cortisone treatment. Infect Immun. 1996;64(4):1488–90.
Article
CAS
PubMed
PubMed Central
Google Scholar
Brière F, Bridon JM, Chevet D, Souillet G, Bienvenu F, Guret C, et al. Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA. J Clin Invest. 1994;94(1):97–104.
Article
PubMed
PubMed Central
Google Scholar
Patel KK, Vicencio AG, Du Z, Tsirilakis K, Salva PS, Webley WC. Infectious Chlamydia pneumoniae is associated with elevated interleukin-8 and airway neutrophilia in children with refractory asthma. Pediatr Infect Dis J. 2010;29(12):1093–8.
Article
PubMed
Google Scholar
Hahn DL, Schure A, Patel K, Childs T, Drizik E, Webley W. Chlamydia pneumoniae-specific IgE is prevalent in asthma and is associated with disease severity. PLoS ONE. 2012;7(4):e35945.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kim RY, Horvat JC, Pinkerton JW, Starkey MR, Essilfie AT, Mayall JR, et al. MicroRNA-21 drives severe, steroid-insensitive experimental asthma by amplifying phosphoinositide 3-kinase–mediated suppression of histone deacetylase 2. J Allergy Clin Immunol. 2017;139(2):519–32.
Article
CAS
PubMed
Google Scholar
Schleich FN, Graff S, Guissard F, Henket M, Paulus V, Louis R. Asthma in elderly is characterized by increased sputum neutrophils, lower airway caliber variability and air trapping. Respir Res. 2021;22(1):15.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ten BA, Van Dissel JT, Sterk PJ, Zwinderman AH, Rabe KF, Bel EH. Persistent airflow limitation in adult-onset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infection. J Allergy Clin Immunol. 2001;107(3):449–54.
Article
Google Scholar
Weiss SG, Newcomb RW, Beem MO. Pulmonary assessment of children after chlamydial pneumonia of infancy. J Pediatr. 1986;108(5 Pt 1):659–64.
Article
CAS
PubMed
Google Scholar
Ansarin K, Abedi S, Ghotaslou R, Soroush MH, Ghabili K, Chapman KR. Infection with Mycoplasma pneumoniae is not related to asthma control, asthma severity, and location of airway obstruction. Int J Gen Med. 2011;4:1–4.
Google Scholar
Brusselle GG, Vanderstichele C, Jordens P, Deman R, Slabbynck H, Ringoet V, et al. Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial. Thorax. 2013;68(1468–3296 (Electronic)):322–9.
Article
PubMed
Google Scholar
Kraft M, Cassell GH, Pak J, Martin RJ. Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin. Chest. 2002;121(6):1782–8.
Article
CAS
PubMed
Google Scholar
Black PN, Blasi F, Jenkins CR, Scicchitano R, Mills GD, Rubinfeld AR, et al. Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae. Am J Respir Crit Care Med. 2001;164(4):536–41.
Article
CAS
PubMed
Google Scholar
Hahn DL, Webley W. Chronic Chlamydia pneumoniae lung infection: a neglected explanation for macrolide effects in wheezing and asthma? Lancet Respir Med. 2016;4(3):e8.
Article
PubMed
Google Scholar
Sutherland ER, King TS, Icitovic N, Ameredes BT, Bleecker E, Boushey HA, et al. A trial of clarithromycin for the treatment of suboptimally controlled asthma. J Allergy Clin Immunol. 2010;126(4):747–53.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gibson PG, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, et al. Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial. Lancet. 2017;390(0140–6736 (Linking)):659–68.
Article
CAS
PubMed
Google Scholar